Trials / Completed
CompletedNCT02321683
Evaluation of a New Coating in Cement Less Femoral Stems
No Mid-term Advantage by Electrochemical Deposition of Hydroxyl-apatite in Cementless Femoral Stems. 5-year RSA and DXA Results From a Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- Lars Nordsletten · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to evaluate a new method of applying hydroxyapatite coatings on cement-less femoral stems.
Detailed description
60 patients eligible for total hip replacement will be randomized in to two groups, receiving either femoral stems with plasma sprayed hydroxyapatite coating or stems with electrochemically deposited hydroxyapatite. This patients will be followed for at least 5 years. The outcome is evaluated by comparing stability measured by RSA and periprosthetic bone remodeling measured by bone densitometry.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Taperloc | Femoral stem with electrochemical deposition of hydroxyapatite |
Timeline
- Start date
- 2003-12-01
- Primary completion
- 2005-06-01
- Completion
- 2008-12-01
- First posted
- 2014-12-22
- Last updated
- 2014-12-22
Source: ClinicalTrials.gov record NCT02321683. Inclusion in this directory is not an endorsement.